Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and cyclin d1

arsenic trioxide has been researched along with cyclin d1 in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawakami, K; Kawamoto, K; Shi, C; Tsuchida, T; Zhao, S1
Hee Cho, Y; Hyuck Im, Y; Hyun Park, W; Ki Kang, W; Kim, K; Lee, MH; Oh Park, J; Park, K; Won Jung, C1
Hayash, H; Horii, T; Kitamura, K; Kobayashi, M; Maekawa, M; Naito, K; Nakamura, S; Naoe, T; Ohnishi, K; Ohno, R; Sahara, N; Shigeno, K; Shinjo, K; Takeshita, A1
Ai, Z; Liu, H; Lu, W; Qin, X; Shen, Z; Sou, T; Ton, S1
Tchounwou, PB; Yedjou, CG1
Cox, AJ; Davis, BH; Davis, KT; Fang, G; Hock, JM; Li, X; Liu, Y; Sullivan, C1
Chen, Z; Jung, HJ; McCarty, N1
Kwong, YL; Lo, RK1
Drzewucka, J; Gackowska, L; Gagat, M; Grzanka, A; Litwiniec, A; Zuryń, A1
Chang, SH; Hong, SC; Jeong, JH; Jung, JM; Kim, GS; Lee, WS; Lu, JN; Nagappan, A; Yun, JW1
Roszak, J; Smok-Pieniążek, A; Stępnik, M1

Trials

1 trial(s) available for arsenic trioxide and cyclin d1

ArticleYear
Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.
    Annals of hematology, 2014, Volume: 93, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lymphoma, Mantle-Cell; Male; Oxides; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Retinoblastoma Protein; Transcription, Genetic; Ubiquitination

2014

Other Studies

10 other study(ies) available for arsenic trioxide and cyclin d1

ArticleYear
Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
    International journal of oncology, 2002, Volume: 21, Issue:1

    Topics: Arsenic Trioxide; Arsenicals; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Division; Cyclin B; Cyclin B1; Cyclin D1; Dose-Response Relationship, Drug; Flow Cytometry; Glioblastoma; Humans; Oxides; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2002
Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.
    Biochemical and biophysical research communications, 2003, Jan-03, Volume: 300, Issue:1

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Carcinoma, Renal Cell; Caspases; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Humans; Kidney Neoplasms; Oxides; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Tumor Cells, Cultured

2003
Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Oxides; Proto-Oncogene Proteins c-bcl-2

2004
Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor.
    Biochemical and biophysical research communications, 2007, Aug-31, Volume: 360, Issue:3

    Topics: Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cyclin D1; Down-Regulation; Gallbladder Neoplasms; Humans; Oxides; Sp1 Transcription Factor; Transcription, Genetic; Transfection

2007
Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide.
    Molecular and cellular biochemistry, 2009, Volume: 331, Issue:1-2

    Topics: Arsenic Trioxide; Arsenicals; Cyclin A1; Cyclin D1; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Neoplasm Proteins; Oxides; Proto-Oncogene Proteins c-fos; Response Elements; Tubulin; Tumor Suppressor Protein p53

2009
Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Journal of cellular biochemistry, 2010, Dec-15, Volume: 111, Issue:6

    Topics: Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Flow Cytometry; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nuclear Proteins; Oxides; p38 Mitogen-Activated Protein Kinases; Protein Stability; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species

2010
Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma.
    American journal of hematology, 2012, Volume: 87, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Drug Synergism; Humans; Lymphoma, Mantle-Cell; Oxides; Pyrazines

2012
The influence of arsenic trioxide on the cell cycle, apoptosis and expression of cyclin D1 in the Jurkat cell line.
    Acta histochemica, 2014, Volume: 116, Issue:8

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Death; Cell Line; Cyclin D1; Humans; Jurkat Cells; Microscopy, Electron, Transmission; Oxides

2014
Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; CDC2 Protein Kinase; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Activation; G2 Phase Cell Cycle Checkpoints; Humans; Membrane Potential, Mitochondrial; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Time Factors

2017
Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2017, Volume: 26, Issue:9

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cyclin D1; Drug Resistance, Neoplasm; Forkhead Box Protein O1; Gene Expression Profiling; Genes, jun; HL-60 Cells; Humans; Oxides; Phosphatidylinositol 3-Kinases; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Signal Transduction

2017